Recolony AG becomes Adularia AG
07-02-2025 – Recolony is now Adularia. This change reflects an important shift in the company’s strategic direction and an ongoing commitment to advancing cancer treatments.
Originally focused on developing a Live Biotherapeutic Product (LBP) from the microbiome, a groundbreaking discovery (the mechanism behind the anti-tumor effects observed with the bacterial product) has led to pivoting the research focus to the development of a small molecule that targets the same mechanism, providing a more defined and targeted approach to oncology therapy.
This strategic shift marks a new era for the company.
